Table 4.
Summary of published data on infections related to gastrostomy placement in patients with ventriculoperitoneal shunts
| Investigator | Study design | Method of gastrostomy | Order of PEG & VP shunt | n | VP shunt infection rate | Interval between PEG & VP shunt | Control group | VP shunt infection rate in control group | Antibiotic used |
| Graham et al[17] | Prospective | Percutaneous endoscopic | VP→PEG | 15 | 0% | 2.2 wk | None | - | Cefazolin |
| Sane et al[18] | Retrospective | Fluoroscopic | VP→PEG | 23 | 9% (2/23) | At least 4 wk | None | - | None |
| Taylor et al[19] | Retrospective | Percutaneous endoscopic | Simultaneous | 16 | 50% (8/16) | - | VP shunt and tracheostomy without PEG | 0% (0/21) | Yes (unspecified) |
| Baird et al[20] | Retrospective | Percutaneous endoscopic | VP→PEG | 6 | 0% | 33 d | None | - | Cefazolin |
| Schulman et al[21] | Retrospective | Percutaneous endoscopic | VP→PEG | 39 | 5% (2/39) | 43.1 d | None | - | 72% received (unspecified) |
| Nabika et al[22] | Retrospective | Percutaneous endoscopic | Both | 23 | 17.4% (4/23) | 29.3 d | Only VP shunt | 4.9% | Cefazolin |
| PEG→VP | 12 | 25% (3/12) | 27.2 d | (6/123) | |||||
| VP→PEG | 11 | 9.1% (1/11 | 39.2 d | (P = 0.0519) | |||||
| Roeder et al[23] | Retrospective | Percutaneous endoscopic and surgical | Both | 55 | 12.7% (7/55) | - | Only PEG | - | 90.9% received (unspecified) |
| PEG→VP | 30 | 16.6% (5/30) | |||||||
| VP→PEG | 25 | 8% (2/25) | |||||||
| This study | Retrospective | Percutaneous endoscopic | VP→PEG | 7 | 0% (0/7) | 308.7 d | Only PEG | - | Yes (unspecified) |